Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 589
Selected: 0
NCT IDTitle
NCT07858630Radiotherapy Target Volume Delineation in Locally Advanced Esophageal Cancer in the Immunotherapy Era
NCT06509919Application of a Novel Model Based on Plasma cfDNA Assay and MRl Imaging in the Detection of Prostate Cancer
NCT04887636Baseline Study of Vaginal Microbiota in Healthy Chinses Female Population
NCT06435767Quantitative Nodal Burden as a Determinant Identifying Ampullary Adenocarcinoma Patients Benefiting From Adjuvant Chemotherapy
NCT02916095Kanitinib in Treating Patients With Advanced Solid Tumors
NCT06350370Short-term and Long-term Outcomes of Colorectal Cancer Treated With Natural Orifice Specimen Extraction Surgery : a National Registry-based Study
NCT07034742Exploratory Study on the Application of Molecular Residual Disease (MRD) in Postoperative Treatment of Gastric Cancer
NCT06858969Chidamide in Combination With PD-1 Inhibitor, Bevacizumab, and XELOX for Metastatic Colorectal Cancer
NCT06509022Longitudinal Study on the Evolution Trend and Influencing Factors of Postoperative Reflux of Esophageal Cancer Based on PEPTEST Technique
NCT02734680IORT Followed by CCRT or SBRT for Locally Advanced Pancreatic Cancer
NCT07432594Neoadjuvant Aitua (PD-1/CTLA-4 Bispecific) Plus Nab-Paclitaxel and Carboplatin for Advanced High-Grade Serous Ovarian Cancer
NCT07279961A Multicenter Study on the Safety and Functionality Evaluation of Anastomotic Redo Surgery
NCT06314542Quantitative Evaluation of the Impact of Relaxing Eligibility Criteria for Lung Cancer Based on Real-world Data
NCT04213937Nab-paclitaxel Versus Topotecan As Second-Line Treatment for Patients With Extensive Stage Small Cell Lung Cancer
NCT01287624Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Paclitaxel in Triple Negative Breast Cancer (TNBC)
NCT06421376Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer
NCT04571476Diagnostic Value of UTB and TB for PPL
NCT03137368A Study to Evaluate Exemestane Tablets Combined With Ovarian Function Suppression/Ablation in Treatment of Premenopausal Breast Cancer Patients With CYP2D6*10 Mutations (STEP)
NCT06509009Nimotuzumab Combined With TGP as First-line Therapy in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma
NCT07405047Fractionated Stereotactic Radiotherapy for Limited Small Volume Brain Metastases
NCT07187167Efficacy and Safety of the RD Regimen(Lenalidomide, Dexamethasone) for Rosai-Dorfman Disease
NCT06577792Lobectomy-First vs. Lymphadenectomy-First for Operable NSCLC (LOFTY)
NCT05198154ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC
NCT07132502Treatment Intermittent Periods Based on ctDNA-MRD(Circulating Tumor DNA-minimal Residual Disease) Status in Advanced HER2-Positive Breast Cancer
NCT05444491Application of Polygenic Methylation Markers in Postoperative Recurrence Monitoring of Colorectal Cancer
NCT07014202Consolidation Radiotherapy vs. Observation in Oligoresidual Advanced Non-Small Cell Lung Cancer After Chemo-Immunotherapy
NCT07239245Study to Evaluate the Efficacy and Safety of Neo-Adjuvant TACE and Atezolizumab Plus Bevacizumab Therapy for High-Risk Recurrent Hepatocellular Carcinamo
NCT06483672Furmonertinib Combined With Anlotinib in Lung Adenocarcinoma Patients With EGFR Mutations and Brain Metastases
NCT05497739Intraperitoneal Chemotherapy Guided by the Detection of DNA in Peritoneal Lavage Fluid in Patients With Gastric Cancer
NCT07890051Chaigui Jieyu Qufa Decoction for CRF in Driver Gene-negative Lung Adenocarcinoma Trial
NCT06667622Sodium Glycididazole Reduces the Adverse Reactions of Concurrent Chemoradiotherapy
NCT06793813Cadonilimab in Patients (Pts) with Advanced Non-small Cell Lung Cancer (NSCLC)
NCT07013461International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer
NCT07232654Iparomlimab/Tuvonralimab Injection Plus CCRT in LACC
NCT06170710Postoperative CCRT Followed by Immunotherapy in High-Risk LA HNSCC
NCT06319404Immune Function of Colorectal Cancer Lymph Nodes
NCT01391260Radiotherapy Combined With Iressa for EGFR Mutation Positive Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC)
NCT04320979Postmastecomy Internal Mammary Nodal Irradiation for High-risk Breast Cancer Patients
NCT06768125Hypofractionated Radiotherapy for HNSCC in Elderly Patients
NCT07507058Hypofractionated Radiotherapy for Postoperative Intermediate-Risk Head and Neck Squamous Cell Carcinoma
NCT06591078Evaluation of Clinical Efficacy of Acupuncture in Improving Immune Response in Patients With Cervical Cancer
NCT01733589Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC
NCT06540950Efficacy and Safety of Concurrent Chemoradiotherapy With Oral Vinorelbine in Patients With Non-small Cell Lung Cancer
NCT06585878A Prospective Registry Study of Stereotactic Ablative Radiotherapy (SABR) for Oligometastatic/Oligometastatic Renal Cell Carcinoma
NCT07359404Sacituzumab Govitecan Plus Bevacizumab in Metastatic TNBC
NCT07735858Microfluidic Urinary Exosome-Based Diagnostic Model for Bladder Cancer
NCT06709885HDAC Inhibitor Combination With Chemoimmunotherapy in the Neoadjuvant Treatment of pMMR Locally Advanced Colon Cancer
NCT04339660Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia
NCT05762900Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients
NCT06771609Phase II Clinical Trial of PD-L1 in Combination With Vinorelbine + Cyclophosphamide + Capecitabine (VEX) Metronomic Chemotherapy With or Without Radiotherapy for Advanced Triple-negative Breast Cancer.